Regencell Bioscience Holdings Ltd (RGC) — Financial Flexibility Index
Regencell Bioscience Holdings Ltd (RGC) has a Financial Flexibility Index of -1.44x as of March 2026. Free cash flow of $-2.59 Million (operating CF $-2.59 Million minus capex $2.00) represents -1% of total liabilities ($1.79 Million). Check RGC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regencell Bioscience Holdings Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Regencell Bioscience Holdings Ltd across 23 annual periods. For the full cash flow conversion analysis, see Regencell Bioscience Holdings Ltd cash flow conversion.
Annual Financial Flexibility Index for Regencell Bioscience Holdings Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Regencell Bioscience Holdings Ltd. Explore Regencell Bioscience Holdings Ltd (RGC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.31x | $-2.96 Million | $-3.11 Million | $895.31K | ▲ +81.8% |
| 2024 | -18.21x | $-4.00 Million | $-4.00 Million | $219.51K | ▼ -133.2% |
| 2023 | -7.81x | $-4.94 Million | $-4.96 Million | $632.32K | ▼ -63.2% |
| 2022 | -4.78x | $-4.49 Million | $-5.27 Million | $938.03K | ▼ -2603.7% |
| 2021 | -0.18x | $-767.31K | $-767.31K | $4.34 Million | ▲ +8.0% |
| 2020 | -0.19x | $-608.74K | $-726.57K | $3.16 Million | ▼ -46.6% |
| 2019 | -0.13x | $-273.15K | $-390.99K | $2.08 Million | ▼ -173.5% |
| 2018 | 0.18x | $660.30 Million | $409.90 Million | $3.70 Billion | ▼ -0.5% |
| 2017 | 0.18x | $625.40 Million | $410.50 Million | $3.48 Billion | ▲ +1.6% |
| 2016 | 0.18x | $620.10 Million | $434.40 Million | $3.51 Billion | ▲ +19.9% |
| 2015 | 0.15x | $505.90 Million | $349.10 Million | $3.43 Billion | ▲ +9.7% |
| 2014 | 0.13x | $459.00 Million | $346.90 Million | $3.42 Billion | ▼ -10.4% |
| 2013 | 0.15x | $435.80 Million | $346.60 Million | $2.91 Billion | ▼ -0.8% |
| 2012 | 0.15x | $440.30 Million | $353.10 Million | $2.91 Billion | ▲ +26.0% |
| 2011 | 0.12x | $357.80 Million | $259.40 Million | $2.98 Billion | ▼ -33.4% |
| 2010 | 0.18x | $519.60 Million | $410.80 Million | $2.88 Billion | ▲ +89.5% |
| 2009 | 0.10x | $270.00 Million | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $373.00 Million | $1.04 Billion | — |